Blepharitis
The regional formulary will not cover all eventualities for infections medicines choices. As with any condition; patient specific factors and sensitivities need to be considered. Please consider this regional formulary advice alongside any relevant local Board guidelines.
For general guidance on administration of drugs to the eye and on control of microbial contamination of eye drops, please see the ‘General information on eye drops’ recommendations.
Self-care (see prescribing notes).
One application every 12 hours trial for 6 weeks. Frequency and duration of treatment is guided by severity and response to treatment.
If signs of meibomian gland dysfunction or rosacea also a problem.
100mg once daily for 2-3 months.
Prescribing Notes:
- Bathing eyes and increased hygiene may be all that is necessary to treat blepharitis. Medical devices for the management of blepharitis should not be prescribed unless specifically recommended by an ophthalmologist. Patients should be advised to purchase instead.
- The eyelid can be cleansed by wetting a cloth with cleanser (for example, baby shampoo diluted 1:10 with warm water) and gently wiping along the lid margins to clear any lid debris.
- Eyelids should be cleaned twice daily initially, then once daily as symptoms improve.
- In addition, a warm compress (a clean cloth warmed with hot water) should be applied to closed eyelids for 5-10 minutes once or twice daily; compresses should not be too hot as this may burn the skin.
- Eyelid hygiene should be continued even when symptoms are well controlled to minimise number and severity of relapses.
- For posterior blepharitis, a brief gentle eyelid massage following the use of a warm compress can help improve expression of Meibomian gland secretions. Care must be taken to prevent mechanical irritation.
- Pressure on the eye area should be avoided in people with glaucoma.
- Cosmetics should be avoided.
- If hygiene measures are ineffective after 2 weeks offer a trial of chloramphenicol eye ointment.
History Notes
30/07/2026
Regional formulary chapter launched.